Clinical experience with authentic recombinant human growth hormone.
Studies of authentic recombinant human growth hormone (rhGH) began very recently in Germany. In this study, one group of patients with hGH deficiency is naïve (no previous hGH treatment), and the second group has been treated with pituitary hGH. The mean age of diagnosis of 17 naïve patients so far accepted is about 8 years; patients who have previously received pituitary hGH are older and slightly taller. No other data are yet available for analysis.
Ranke
M B
MB
D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D006130:Growth Disorders / Q000175:diagnosis / Q000188:drug therapy*; D013006:Growth Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use*; D019382:Human Growth Hormone; D006801:Humans; D007223:Infant; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D019382:Human Growth Hormone; D013006:Growth Hormone